Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Rosner

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsV Gandhi, W Plunkett, S Weller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565A P Venook, M J Egorin, G L Rosner, et al.
Science (New York, N.Y.)|May 6, 1988
Translocation and rearrangement of myeloperoxidase gene in acute promyelocytic leukemiaS C Weil, G L Rosner, M S Reid, et al.
Science (New York, N.Y.)|May 19, 1989
Response: the myeloperoxidase gene in acute promyelocytic leukemiaS C Weil, M S Reid, L A Nilles, et al.
The Pharmacogenomics Journal|April 15, 2015
Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication studyD J Crona, J Ramirez, W Qiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B studyR C Lilenbaum, M J Ratain, A A Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264A P Venook, M J Egorin, G L Rosner, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1992
Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphomaR L Page, D W Macy, G K Ogilvie, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B studyR A Fleming, R L Capizzi, G L Rosner, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsV Gandhi, W Plunkett, S Weller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565A P Venook, M J Egorin, G L Rosner, et al.
Science (New York, N.Y.)|May 6, 1988
Translocation and rearrangement of myeloperoxidase gene in acute promyelocytic leukemiaS C Weil, G L Rosner, M S Reid, et al.
Science (New York, N.Y.)|May 19, 1989
Response: the myeloperoxidase gene in acute promyelocytic leukemiaS C Weil, M S Reid, L A Nilles, et al.
The Pharmacogenomics Journal|April 15, 2015
Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication studyD J Crona, J Ramirez, W Qiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B studyR C Lilenbaum, M J Ratain, A A Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264A P Venook, M J Egorin, G L Rosner, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1992
Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphomaR L Page, D W Macy, G K Ogilvie, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B studyR A Fleming, R L Capizzi, G L Rosner, et al.
Pageof 6